Max Robotics — Global Service Robot Directory + US Certification

About

Brandon C. Chapman is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex gastrointestinal cancers, particularly pancreatic and rectal malignancies. His landmark 2018 study, cited over 150 times, rigorously compared minimally invasive pancreaticoduodenectomy (MIPD) to open surgery using the National Cancer Database, revealing critical insights into how hospital volume affects short-term and oncologic outcomes. This work has helped guide clinical decision-making and surgical training standards. Chapman further demonstrated his expertise in comparative effectiveness research through a propensity-matched analysis of laparoscopic, robotic, and open low anterior resection for rectal cancer, providing evidence that minimally invasive approaches can achieve comparable results. Beyond clinical outcomes, Chapman has made important contributions to patient safety by investigating stray energy transfer in robotic surgery—a previously underrecognized hazard—in both multiport and single-incision platforms. His work on monopolar stray energy has informed best practices for energy device use in the operating room. Through these studies, Chapman has helped shape the safe adoption of robotic and laparoscopic techniques in surgical oncology, earning recognition as a thoughtful investigator dedicated to improving both surgical quality and patient outcomes.